Evanthia Galanis
Overview
Explore the profile of Evanthia Galanis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
178
Citations
10686
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kotecha R, Akdemir E, Kutuk T, Ilgin C, Ahluwalia M, Bi W, et al.
Neuro Oncol
. 2025 Jan;
PMID: 39807850
Background: Despite advances in our understanding of the molecular underpinnings of meningioma progression and innovations in systemic and local treatments, recurrent meningiomas remain a substantial therapeutic challenge. The objective of...
2.
Ellingson B, Sanvito F, Pope W, Cloughesy T, Huang R, Villanueva-Meyer J, et al.
AJNR Am J Neuroradiol
. 2024 Dec;
46(1):221-222.
PMID: 39730160
No abstract available.
3.
Horbinski C, Solomon D, Lukas R, Packer R, Brastianos P, Wen P, et al.
JAMA Oncol
. 2024 Dec;
PMID: 39724142
Importance: Molecular techniques, including next-generation sequencing, genomic copy number profiling, fusion transcript detection, and genomic DNA methylation arrays, are now indispensable tools for the workup of central nervous system (CNS)...
4.
Davar D, Carneiro B, Dy G, Sheth S, Borad M, Harrington K, et al.
J Immunother Cancer
. 2024 Nov;
12(11.
PMID: 39551600
Background: MEDI5395 is a recombinant attenuated Newcastle disease virus engineered to express a human granulocyte-macrophage colony-stimulating factor transgene. Preclinically, MEDI5395 demonstrated broad oncolytic activity, augmented by concomitant programmed cell death-1/programmed...
5.
Sarkaria J, Ballman K, Kizilbash S, Sulman E, Giannini C, Friday B, et al.
JAMA Oncol
. 2024 Oct;
10(12):1637-1644.
PMID: 39480453
Importance: The prognosis for patients with glioblastoma is poor following standard therapy with surgical resection, radiation, temozolomide, and tumor-treating fields. Objectives: To evaluate the combination of veliparib and temozolomide in...
6.
ODwyer P, Wolmark N, Hawkins D, Schnall M, Dancey J, Blanke C, et al.
J Clin Oncol
. 2024 Sep;
42(33):3905-3910.
PMID: 39288338
No abstract available.
7.
Ellingson B, Sanvito F, Cloughesy T, Huang R, Villanueva-Meyer J, Pope W, et al.
AJNR Am J Neuroradiol
. 2024 Jun;
45(12):1846-1856.
PMID: 38926092
Radiographic assessment plays a crucial role in the management of patients with central nervous system (CNS) tumors, aiding in treatment planning and evaluation of therapeutic efficacy by quantifying response. Recently,...
8.
Stergiopoulos G, Concilio S, Galanis E
Curr Treat Options Oncol
. 2024 Jun;
25(7):952-991.
PMID: 38896326
Malignant gliomas are common central nervous system tumors that pose a significant clinical challenge due to the lack of effective treatments. Glioblastoma (GBM), a grade 4 malignant glioma, is the...
9.
Tevaarwerk A, Karam D, Gatten C, Harlos E, Maurer M, Giridhar K, et al.
Cancer
. 2024 Apr;
131(1):e35304.
PMID: 38662502
Introduction: Structured data capture requires defined languages such as minimal Common Oncology Data Elements (mCODE). This pilot assessed the feasibility of capturing 5 mCODE categories (stage, disease status, performance status...
10.
Galanis E, Dooley K, Anderson S, Kurokawa C, Carrero X, Uhm J, et al.
Nat Commun
. 2024 Jan;
15(1):493.
PMID: 38216554
Measles virus (MV) vaccine strains have shown significant preclinical antitumor activity against glioblastoma (GBM), the most lethal glioma histology. In this first in human trial (NCT00390299), a carcinoembryonic antigen-expressing oncolytic...